Homeopathic Drug Product Safety, Quality, and Transparency Act

The Homeopathic Drug Product Safety, Quality, and Transparency Act creates a distinct regulatory category for homeopathic medicines within the Federal Food, Drug, and Cosmetic Act, separating them from conventional drugs that require premarket approval. This legislation mandates that the FDA establish new safety, quality, and labeling standards specifically tailored to homeopathic products, including a requirement to finalize rules on manufacturing practices within three years of enactment. The bill also establishes a temporary advisory committee to provide recommendations on regulation and ensures that products labeled as homeopathic are not subject to false advertising claims if they adhere to traditional homeopathic principles. Additionally, the act clarifies definitions for homeopathic ingredients and updates labeling rules to allow for specific language indicating that intended uses have not been evaluated by the FDA.